Key statistics
As of last trade LivaNova PLC (LIA:DUS) traded at 55.50, -0.89% below its 52-week high of 56.00, set on Feb 04, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 54.50 |
|---|---|
| High | 55.50 |
| Low | 54.00 |
| Bid | 56.00 |
| Offer | 57.50 |
| Previous close | 54.50 |
| Average volume | 0.00 |
|---|---|
| Shares outstanding | 54.61m |
| Free float | 54.41m |
| P/E (TTM) | -- |
| Market cap | 3.59bn USD |
| EPS (TTM) | -4.01 USD |
Data delayed at least 15 minutes, as of Feb 10 2026 15:32 GMT.
More ▼
Press releases
- LivaNova to Announce Fourth-Quarter and Full-Year 2025 Results
- LivaNova to Present at J.P. Morgan Healthcare Conference in January
- LivaNova to Highlight Real-World Evidence from CORE-VNS Study and New Health Economics Analyses at American Epilepsy Society 2025 Annual Meeting
- LivaNova Appoints Lucile Blaise as Global Head of Commercialization, Obstructive Sleep Apnea
- LivaNova to Present at Piper Sandler Healthcare Conference in December
- LivaNova’s VNS Therapy for Drug-Resistant Epilepsy Procedures Receives Increased Provider Reimbursement from U.S. Centers for Medicare & Medicaid Services
- LivaNova Delivers Strategic Roadmap and Long-Range Financial Plan at Investor Day
More ▼
